Clinical Trials Recruitment & Retention
Pharmaceutical innovation depends on clinical trials composed of the right patient participants from diverse communities. To identify the right patients, you’ve got to know how to reach them. We leverage our advocacy and media ties, and connect with patients on digital, social and mobile channels to tell your clinical trial story. We’re familiar with the regulatory parameters around clinical trial communications, and we know how to talk to patients so they feel comfortable and informed.
“Designing an effective trial recruitment communication programme integrated with science is challenging; it requires meticulous understanding and planning, and community outreach. For a large country like India that has multi-linguistic challenges, maintaining the essence of key messaging plays a critical role.”
“Effective clinical trial recruitment is a balancing act among the interests of the sponsors of the trial, the patients being recruited, the families of these patients, the medical centres and third-party investigators implementing the research programme, and the government regulators who oversee the process. In choosing a consultancy to provide communications support for clinical trial recruitment, the sponsor must carefully weigh all of these these factors in judging the quality and cost-effectiveness of the offers being made. Often the consultant’s advice may seem complex or even counter-intuitive, but that is the challenge of this work, and successful clinical trial sponsors will recognize the care that has gone into a sound and, hopefully, winning proposal.”
The latest from our blog
Read our recent posts on strategies for clinical trial recruitment.
Every year GLOBALHealthPR agencies come together for our Annual General Meeting, AGM for short, and it’s a celebrated event! Months in advance partners start circling the dates on calendars, eagerly anticipating the opportunity to learn, share and connect. This past...read more
Despite being somewhat averse to speculation, Guess What’s editorial board asked me to write about trends for 2017. I leave here my 12 guesses.read more
Here at GLOBALHealthPR, we go to all ends of the earth to deliver our clients recipes for successful global and regional communications programmes. With offices in more than 40 countries, we know how to find the right mix of local insights and ingredients in order satisfy the unique tastes and needs of each programme.
In the spirit of the holiday season, we’re sharing some of the traditional recipes that are enjoyed in our local markets around this time of the year, delivered by our expert agency partners. Bon Appetite!read more
I’ve been in Sydney, Australia for just over a week now as a part of the GLOBALHealthPR® Professional Exchange Program. While I’ve done “heaps” of touristy things like check out sweeping views of the city from the Sydney Tower Eye, watched surfers catch some waves at Manly Beach and hung out with koalas at the Wild Life Sydney Zoo, I’ve also gotten a taste of what it’s like to live as a local Aussie. Here are a few things about working with colleagues at our partner agency Team VIVA! that I wanted to share:read more
Today’s post comes to us from Philipp Dieterich, Strategy Expert at GLOBALHealthPR Germany partner, fischerAppelt.
Earlier this year, the German pharma association FSA implemented the Transparency Code, which means that for the first time all pharmaceutical companies in Germany have to publish all monetary contributions they have paid to medical institutions, doctors and other partners throughout the previous year. Technically speaking, this is not a challenging request. However, companies that carry out their duty and publish those numbers let go of the opportunity to establish a new compliance culture and shape communication around it.read more
Recent changes to medicinal marijuana laws and regulations globally have expanded opportunities for medical research and patient care.
These actions are part of a broader global movement of governments and advocates to recognise the potential medicinal benefits of marijuana, which has long been considered solely a harmful recreational drug. These purported medical benefits include aiding in the treatment of epilepsy, PTSD, chronic pain and more.
Here we present three examples of GLOBALHealthPR member countries – Australia, Canada and the United States – that are tackling the legislative issues surrounding the use of medical marijuana.read more